Lamivudine-13C,15N2

Lamivudine-13C,15N2

• CAS Number: 1391052-30-4
• UNSPSC Description: Lamivudine-13C,15N2 is a labelled impurity of Lamivudine (BCH-189). Lamivudine is a nucleoside reverse transcriptase inhibitors (NRTIs), and can inhibit HIV reverse transcriptase 1/2 and the reverse transcriptase of hepatitis B virus[1][2].
• Target Antigen: HIV; Reverse Transcriptase
• Type: Isotope-Labeled Compounds
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/lamivudine-13c-15n2.html
• Solubility: 10 mM in DMSO
• Smiles: O=[13C]1[15N]([C@H]2O[C@@H](C(O)=O)SC2)C=CC(N)=[15N]1
• Molecular Weight: 246.22
• References & Citations: [1]Li, Y.C., [A clinical study on lamivudine treatment for advanced schistosomisis with chronic B hepatits]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, 2013. 25(5): p. 548-9, 551.|[2]Zhang, C.E., et al., [Effects of lamivudine on growth of intestinal characteristic bacteria by microcalorimetry in vitro]. Yao Xue Xue Bao, 2013. 48(10): p. 1590-4.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported